Literature DB >> 26563370

Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.

Manuel Scimeca1,2, Chiara Antonacci1,2, Daniele Colombo1, Rita Bonfiglio1, Oreste Claudio Buonomo3, Elena Bonanno4,5.   

Abstract

Despite the screening program, breast cancer is the commonest cause of cancer death in women in the industrialized world. In this study, we investigate the correlation among poorly differentiated carcinoma, epithelial to mesenchymal transition (EMT) phenomenon, and expression of NF-kB, Sonic Hedgehog (SHH), K-RAS, and PTX3 in breast cancer in 100 breast biopsies. Samples were classified as follows: 30 benign lesions (BL), 30 ductal infiltrating carcinomas low grade (MLG1), and 40 ductal infiltrating carcinomas high grade (MLG3). Expression of vimentin, CD44, β-catenin, NF-kB, SHH, K-RAS, CD44, and PTX3 was studied by immunohistochemistry. The different rate of cells with vimentin, nuclear β-catenin, and CD44 expression in MLG3 as compared with MLG1 and BL suggested that the process of de-differentiation of breast cancer cells could be related to the EMT. Our results showed a significant increase in NF-kB signal in MLG3 (2.33 ± 0.77) with respect to MLG1 (1.26 ± 0.55) and BL (0.86 ± 0.52). SHH expression appeared low in BL (1.00 ± 0.41) and homogenously widespread in MLG1 (1.23 ± 0.63) and MLG3 (1.56 ± 0.54). An important increase in K-RAS signal was observed in MLG3 compared to that in BL (2.20 ± 0.69 vs 0.82 ± 0.59). As regards PTX3, we observed a strong expression in MLG3 (2.00 ± 0.78) with respect to BL (0.58 ± 0.55) and MLG1 (1.53 ± 0.76). The recurring expression of NF-kB, SHH, K-RAS, and PTX3 in vimentin- and CD44-positive breast cancer cells allows to speculate that breast cells acquire the ability to express these molecules in concomitance to EMT phenomenon.

Entities:  

Keywords:  Breast cancer markers; Epithelial to mesenchymal transition; K-RAS; NF-kB; PTX3; Sonic Hedgehog

Mesh:

Substances:

Year:  2015        PMID: 26563370     DOI: 10.1007/s13277-015-4361-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 2.  Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.

Authors:  Tamami Ukaji; Kazuo Umezawa
Journal:  Adv Biol Regul       Date:  2014-07-01

3.  Tetracycline accumulates in Iberis sempervirens L. through apoplastic transport inducing oxidative stress and growth inhibition.

Authors:  G Di Marco; A Gismondi; L Canuti; M Scimeca; A Volpe; A Canini
Journal:  Plant Biol (Stuttg)       Date:  2013-09-30       Impact factor: 3.081

Review 4.  The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

Authors:  Danny R Youlden; Susanna M Cramb; Nathan A M Dunn; Jennifer M Muller; Christopher M Pyke; Peter D Baade
Journal:  Cancer Epidemiol       Date:  2012-03-27       Impact factor: 2.984

Review 5.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

Review 6.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 7.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

Authors:  Caitlin D May; Nathalie Sphyris; Kurt W Evans; Steven J Werden; Wenjun Guo; Sendurai A Mani
Journal:  Breast Cancer Res       Date:  2011-02-08       Impact factor: 6.466

Review 8.  NF-κB in cellular senescence and cancer treatment.

Authors:  Hua Jing; Soyoung Lee
Journal:  Mol Cells       Date:  2014-03-03       Impact factor: 5.034

9.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  Arch Pathol Lab Med       Date:  2013-10-07       Impact factor: 5.534

10.  Assessment of metal contaminants in non-small cell lung cancer by EDX microanalysis.

Authors:  M Scimeca; A Orlandi; I Terrenato; S Bischetti; E Bonanno
Journal:  Eur J Histochem       Date:  2014-09-12       Impact factor: 3.188

View more
  21 in total

1.  Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.

Authors:  Clémence Thomas; Whitney Henry; Benjamin G Cuiffo; Anthony Y Collmann; Elisabetta Marangoni; Vanessa Benhamo; Manoj K Bhasin; Cheng Fan; Laetitia Fuhrmann; Albert S Baldwin; Charles Perou; Anne Vincent-Salomon; Alex Toker; Antoine E Karnoub
Journal:  Sci Signal       Date:  2017-02-21       Impact factor: 8.192

Review 2.  Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis.

Authors:  Busra Buyuk; Sha Jin; Kaiming Ye
Journal:  Cell Mol Bioeng       Date:  2021-09-02       Impact factor: 3.337

3.  Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance.

Authors:  Rita Bonfiglio; Manuel Scimeca; Nicola Toschi; Chiara Adriana Pistolese; Elena Giannini; Chiara Antonacci; Sara Ciuffa; Virginia Tancredi; Umberto Tarantino; Loredana Albonici; Elena Bonanno
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-05-09       Impact factor: 2.673

4.  Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics.

Authors:  Yi-Hung Sun; Ying-Hsiang Chou; Chun-Hao Wang; Yi-Hsuan Hsiao; Chung-Yuan Lee; Shun-Fa Yang; Po-Hui Wang
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

Review 5.  EMT in Breast Carcinoma-A Review.

Authors:  Joema Felipe Lima; Sharon Nofech-Mozes; Jane Bayani; John M S Bartlett
Journal:  J Clin Med       Date:  2016-07-14       Impact factor: 4.241

6.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

7.  Energy Dispersive X-ray (EDX) microanalysis: A powerful tool in biomedical research and diagnosis.

Authors:  Manuel Scimeca; Simone Bischetti; Harpreet Kaur Lamsira; Rita Bonfiglio; Elena Bonanno
Journal:  Eur J Histochem       Date:  2018-03-15       Impact factor: 3.188

8.  PTX3 Effects on Osteogenic Differentiation in Osteoporosis: An In Vitro Study.

Authors:  Chiara Greggi; Ida Cariati; Federica Onorato; Riccardo Iundusi; Manuel Scimeca; Umberto Tarantino
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.

Authors:  Hidehiko Takigawa; Yasuhiko Kitadai; Kei Shinagawa; Ryo Yuge; Yukihito Higashi; Shinji Tanaka; Wataru Yasui; Kazuaki Chayama
Journal:  Neoplasia       Date:  2017-04-20       Impact factor: 5.715

10.  Switch of the ovarian cancer cell to a calcifying phenotype in the calcification of ovarian cancer.

Authors:  Jirui Wen; Zhiwei Zhao; Liwei Huang; Liang Li; Jiman Li; Ye Zeng; Jiang Wu; Yali Miao
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.